SU-14813   Click here for help

GtoPdb Ligand ID: 5712

Synonyms: SU014813 | SU14813
Compound class: Synthetic organic
Comment: SU-14813 is an oral, multitargeted receptor tyrosine kinase inhibitor targeting VEGFRs, PDGFRs, KIT, and FLT3 [2-3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 103.26
Molecular weight 442.2
XLogP -0.66
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)C=C1C(=O)Nc2c1cc(F)cc2)C
Isomeric SMILES O[C@H](CN1CCOCC1)CNC(=O)C1C(=NC(=C1C)/C=C/1\C(=O)Nc2c1cc(F)cc2)C
InChI InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,21,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-,21?/m0/s1
InChI Key XWPFYHDOZULRTD-ROUJOJKSSA-N
Bioactivity Comments
SU-14813 exhibits potent antiangiogenic and antitumour activity in vivo [3].
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
kinase insert domain receptor Primary target of this compound Hs Inhibitor Inhibition 8.6 pKd - 1
pKd 8.6 (Kd 2.3x10-9 M) [1]
fms related receptor tyrosine kinase 1 Primary target of this compound Hs Inhibitor Inhibition 8.7 pIC50 - 3
pIC50 8.7 (IC50 2x10-9 M) [3]
platelet derived growth factor receptor beta Primary target of this compound Hs Inhibitor Inhibition 8.4 pIC50 - 3
pIC50 8.4 (IC50 4x10-9 M) [3]
KIT proto-oncogene, receptor tyrosine kinase Primary target of this compound Hs Inhibitor Inhibition 7.8 pIC50 - 3
pIC50 7.8 (IC50 1.5x10-8 M) [3]
kinase insert domain receptor Primary target of this compound Hs Inhibitor Inhibition 7.3 pIC50 - 3
pIC50 7.3 (IC50 5x10-8 M) [3]
fibroblast growth factor receptor 1 Hs Inhibitor Inhibition 5.5 pIC50 - 3
pIC50 5.5 (IC50 3.5x10-6 M) [3]